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Introduction
Juvenile Systemic Lupus Erythematosus (JSLE) is an
autoimmune disease characterized by multiple organ
involvement. The nervous system is often affected, with a
higher frequency in children than in adults.
Objectives
To examine prevalence and features of neuropsychiatric
manifestations in JSLE, focusing on headache.
Methods
The records of all patients satisfying the ACR criteria for
JSLE admitted to our Hospital from 1980 to May 2014
were retrospectively reviewed. Disease activity at onset was
measured by SLE disease activity index (SLEDAI); organ
damage was assessed at last follow-up using the SLICC/
ACR Damage Index (SDI). Using the 1999 ACR nomen-
clature for neuropsychiatric (NP) lupus syndromes,
patients were divided in patients with (NPSLE) and with-
out (nNPSLE) NP involvement. Headache was defined as
in the ACR nomenclature (ACR headache), as in SLEDAI
(SLEDAI headache) and as “severe persistent headache;
may be migrainous” (LHA).
Results
Of 97 patients included in the study 84,5% were female.
The female to male ratio was the same both in NPSLE
and nNPSLE. Our population was predominantly white
(90,7%). The mean ± SD age at onset was 11,8 ± 6,9 years
and at diagnosis 12,9 ± 6,9 years. Mean ± SD length of
follow-up was 6,6 ± 5,7 years. The mean ± SD age at onset
of NP manifestations was 14,4 ± 9,3 years. The overall pre-
valence of NPSLE manifestations was 52,6%; NP syn-
dromes were already present at the onset in 20,6% JSLE
patients. In Table 1 we display the most common central
nervous system syndromes reported in our NPSLE
patients. The mean SLEDAI score at onset was 15,5 ± 7,7
in NPSLE and 12,6 ± 6,3 in nNPSLE. Mean SDI was 0,84
± 0,9 in NPSLE and 0,5 ± 1,3 in nNPSLE. NP involvement
was significantly associated with a SDI ≥ 1 (p < 0,05).
Lupus anticoagulant (LAC) was present in 50,9% NPSLE
and 19,6% nNPSLE patients. Antiphospholipid antibodies
(APL) were detected in 50,9% NPSLE and 10% nNPSLE
patients. In the subset of NPSLE patients, positivity of
LAC and APL wasn’t significantly associated with head-
ache. Magnetic Resonance Imaging (MRI) was performed
in 37 NPSLE patients and was normal in 12. LHA defini-
tion was fulfilled in all patients with headache and patho-
logical MRI.
Conclusion
Consistently with the literature, more than a half of our
JSLE patients presented NP involvement. Headache is a
frequent manifestation: it was reported in 38,8% JSLE
and 72,5% NPSLE patients. Headache in JSLE deserves
an accurate investigation. In the subset of NPSLE
patients, positivity of LAC and APL did not significantly
correlate with headache, which may also be due to small
number of cases. Further prospective studies are needed
to better understand and define headache in JSLE.
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Table 1 Most common central nervous system neuropsychiatric syndromes
Overall (n. of patients) At onset (n. of patients) Later during the disease course (n. of patients)
Psychosis 5 2 3
Seizure disorders 7 5 2
Cerebrovascular disease 8 3 5
- ACR headache 37 9 28
- SLEDAI headache 1 - 1
- LHA 24 5 19
Movement disorder (chorea) 6 5 1
Mood disorder 8 2 6
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